Haleon PLC (HLN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Haleon PLC (HLN) has a cash flow conversion efficiency ratio of 0.032x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX513.50 Million ≈ $62.48K USD) by net assets (GBX16.00 Billion ≈ $1.95 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Haleon PLC defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Haleon PLC - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Haleon PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Haleon PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Haleon PLC ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Reckitt Benckiser Group PLC
LSE:RKT
|
0.191x |
|
Shandong Minhe Animal Husbandry Co Ltd
SHE:002234
|
0.026x |
|
Hotel Majestic Cannes
PA:MLHMC
|
0.033x |
|
Lontrue Co Ltd
SHE:300175
|
-0.111x |
|
Viking Line Abp
HE:VIK1V
|
0.151x |
|
Southern States Bancshares Inc
NASDAQ:SSBK
|
0.033x |
|
Shandong Sinobioway Biomedicine Co Ltd
SHE:002581
|
-0.043x |
|
HPF Co Ltd
SHE:300350
|
-0.025x |
Annual Cash Flow Conversion Efficiency for Haleon PLC (2019–2024)
The table below shows the annual cash flow conversion efficiency of Haleon PLC from 2019 to 2024. For the full company profile with market capitalisation and key ratios, see Haleon PLC (HLN) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | GBX16.22 Billion ≈ $1.97 Million |
GBX2.30 Billion ≈ $279.97K |
0.142x | +12.98% |
| 2023-12-31 | GBX16.73 Billion ≈ $2.04 Million |
GBX2.10 Billion ≈ $255.51K |
0.126x | +0.14% |
| 2022-12-31 | GBX16.46 Billion ≈ $2.00 Million |
GBX2.06 Billion ≈ $251.01K |
0.125x | +144.80% |
| 2021-12-31 | GBX26.48 Billion ≈ $3.22 Million |
GBX1.36 Billion ≈ $164.99K |
0.051x | -4.56% |
| 2020-12-31 | GBX26.22 Billion ≈ $3.19 Million |
GBX1.41 Billion ≈ $171.19K |
0.054x | +87.12% |
| 2019-12-31 | GBX27.41 Billion ≈ $3.34 Million |
GBX786.00 Million ≈ $95.63K |
0.029x | -- |
About Haleon PLC
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene… Read more